[1] Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol, 2007,35(6):757-766.
[2] Gujral JS, Farhood A, Bajt ML, et al. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology,2003,38(2):355–363.
[3] Maria J P, Briz O.Bile-acid-induced cell injury and protection. World J Gastroenterol,2009,15(14):1677-1689.
[4] 中华医学会外科学分会胆道外科学组. 急性胆道系统感染的诊断和治疗指南(2011年版). 中华消化外科杂志,2011,10:9-13.
[5] Chang WH, Chu CH, Wang TE,et al. Acute transient hepatocellular injury in cholelithiasis and cholecystitis without evidence of choledocholithiasis.World J Gastroenterol,2009,15(30):3788-3792.
[6] Tsuneyama K, Baba H, Morimoto Y, et al. Primary biliary cholangitis: its pathological characteristics and immunopathological mechanisms. J Med Invest, 2017, 64:7–13.
[7] Hydes Theresa J, Blunt Matthew D, Jennifer N, et al. Constitutive activation of natural Killer cells in primary biliary cholangitis. Front Immunol,2019,10:3112.
[8] Gao H, Cao HE, Bukun J, et al. Abnormal xpression of ERα in cholangiocytes of patients with primary biliary cholangitis mediated intrahepatic bile duct inflammation. Front Immunol, 2019, 10:2815.
[9] Chapman R, Cullen S. Etiopathogenesis of primary sclerosing cholangitis.World J Gastroenterol,2008,45(21):3350-3359.
[10] Chen YY, Arndtz K, Webb G,et al. Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis. JHEP Rep,2019,1(5):369-736.
[11] Trivedi PJ, Tickle J, Na mdal Vesterhus M,et al. Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner. Gut,2018,67(6):1135-1145.
[12] 祝达,马海林,马志萍,等.胆囊炎和胆系结石手术患者肝组织病理分析57例.世界华人消化杂志,2014,22(12):1734-1738.
[13] Scheuer PJ. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc,1998,73(2):179-183.
[14] Peter F,Pollheimer Marion J, Ulrich B,et al. Characterization of animal models for primary sclerosing cholangitis (PSC).J Hepatol,2014,60(6):1290-1303.
[15] Liu T, Yang HP, Fan W, et al. Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer. Gastroenterology,2018,155(2):557-571.
[16] Tong C, Li J, Lin W, et al. Inhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL1β and IL18 expression. Exp Therap Med, 2021, 21(3):241.
[17] Takanori K,Schuster Rebecca M, Goetzman Holly S, et al. Cell-specific regulatory effects of CXCR2 on cholestatic liver injury. Am J Physiol Gastrointest Liver Physiol,2019,317(6):773-783. |
